Calunod, Ghaven Kherl O.

HRN: 27-35-71  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2025
CEFUROXIME 750MG (VIAL)
06/22/2025
06/28/2025
IV
470mg
Q8h
Acute Bacterial Infection
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: